Optical imaging market to hit $1.9B in 2018, says report

Aug. 14, 2013
A new market research report published by MarketsandMarkets forecasts that the optical imaging technologies market will reach $1.9 billion by 2018, at an estimated compound annual growth rate (CAGR) of 11.37 percent from 2013 to 2018.

A new market research report published by MarketsandMarkets forecasts that the optical imaging technologies market will reach $1.9 billion by 2018, at an estimated compound annual growth rate (CAGR) of 11.37 percent from 2013 to 2018. Technologies covered in the report include optical coherence tomography (OCT), hyperspectral imaging (HSI), near-infrared spectroscopy (NIRS), and photoacoustic tomography (PAT), all of which are expected to grow in the next five years for clinical diagnostics, clinical research, and the life sciences.

Related: Photoacoustic tomography is ready to revolutionize

Optical imaging has the potential to revolutionize clinical diagnostics and drug discovery in healthcare, as it uses light to assess optical properties of tissues noninvasively and, therefore, with fewer side effects. What's more, it doesn't use ionizing radiation and offers significant cost savings over conventional radiological technologies.

Currently, OCT has over 70% of the market share in the optical imaging market, with an expected 4 percent CAGR by the end of 2018. OCT is widely accepted for clinical diagnostics in ophthalmology, dentistry, cardiology, dermatology, and cancer detection. HSI, NIRS, and PAT are emerging technologies in optical imaging market, with a few players. HSI and NIRS are currently used for biomedical research and drug discovery in the areas of dermatology and neurology. These technologies are expected to grow exponentially, with a few units now readily available in the market. PAT recently made its entry into market for cancer detection, and recent advances have made it possible to enhance its ability in recovering both optical and acoustic properties that adds to its potential to better differentiate benign from malignant lesions.

Key players profiled in the report are Michelson Diagnostics, Heidelberg Engineering, Carl Zeiss Meditec, Volcano Corporation, Topcon Medical Systems, St. Jude Medical, Headwall Photonics, Cytoviva, ChemImage Corporation, Bioptigen, Raytheon ELCAN Optical Technologies, Somanetics Corporation, and ASE Optics.

For more information, please visit www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Sponsored Recommendations

Demonstrating Flexible, Powerful 5-axis Laser Micromachining

Sept. 18, 2024
Five-axis scan heads offer fast and flexible solutions for generating precise holes, contoured slots and other geometries with fully defined cross sections. With a suitable system...

Enhance Your Experiments with Chroma's Spectra Viewer

Sept. 5, 2024
Visualize and compare fluorescence spectra with our interactive Spectra Viewer tool. Easily compare and optimize filters and fluorochromes for your experiments with this intuitive...

Optical Filter Orientation Guide

Sept. 5, 2024
Ensure optimal performance of your optical filters with our Orientation Guide. Learn the correct placement and handling techniques to maximize light transmission and filter efficiency...

Ensure Optimal Performance with Shortpass Filters

Sept. 5, 2024
Achieve precise wavelength blocking with our Shortpass Filters. Ideal for applications requiring effective light transmission and cutoff, these filters ensure optimal performance...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!